In addition, transcriptome meta-analysis using 13 independent microarray datasets from CF; chronic pulmonary disorders, including COPD, IPF, and asthma; and environmental conditions, such as smoking and epithelial injury, recently identified that the CFTR gene was of potential therapeutic significance for these disorders [49]. This evidence concerns the gene CFTR and cystic fibrosis.